Insights from 2024 ESGO Annual Meeting

 

Videos
09:07

Insights from 2024 ESGO Annual Meeting

Surgical Principles in 1L and Relapse for Uterine Sarcoma

FEATURING Jalid Sehouli
  • 43 views
  • April 25, 2024
08:20

Insights from 2024 ESGO Annual Meeting

Risk Stratification of Endometrial Cancer & Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Disease

FEATURING Jalid Sehouli
  • 109 views
  • April 25, 2024
  • 1
08:19

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Oncology Clinical Trials - Randomization Is Not a Holy Grail"

FEATURING David Cibula
  • 2 views
  • April 19, 2024
09:07

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "SENTIX Trial - Survival of Patients With Early Stages Cervical Cancer After SLN Biopsy Without Systematic Pelvic Lymphadenectomy"

FEATURING David Cibula
  • 78 views
  • April 19, 2024
07:05

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Understanding and Targeting BRCA & HRD Mechanisms in Gynecologic Cancer"

FEATURING Viola Heinzelmann-Schwarz
  • 97 views
  • March 29, 2024
  • 1
10:51

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "The Heterogeneity of PARPi and BRCAm in Gynecologic Cancer"

FEATURING Viola Heinzelmann-Schwarz
  • 87 views
  • March 29, 2024
12:21

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gynecologic Cancers and Possible Solutions"

FEATURING Viola Heinzelmann-Schwarz
  • 129 views
  • March 29, 2024
  • 1
18:16

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer"

FEATURING Jean-Emmanuel Kurtz
  • 181 views
  • March 22, 2024
  • 2
03:51

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "IMAGYN-050 Trial - Benefit From Atezolizumab in Pts With a Poor Prognostic Ovarian Cancer in 1L Setting"

FEATURING Benoit You
  • 48 views
  • March 22, 2024
07:21

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "COPELIA Trial - Cediranib With Weekly Paclitaxel or Olaparib vs. Weekly Paclitaxel Chemo for Advanced/Recurrent Endometrial Cancer"

FEATURING Andrew Clamp
  • 72 views
  • March 22, 2024
16:37

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Molecular Profiling in Endometrial Cancer - Pitfalls and Challenges"

FEATURING Xavier Matias-Guiu
  • 112 views
  • March 19, 2024
  • 3
05:01

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "The Movie Trial - Safety & Efficacy of Durvalumab + Tremelimumab + Metronomic Oral Vinorelbine in Pts With Recurrent/Metastatic Cervical Cancer"

FEATURING Jean-Sebastien Frenel
  • 49 views
  • March 19, 2024